loader2
Partner With Us NRI

Company details

148.05
154.30
60.10
310.60
6M Return -19.78%
1Y Return 117.20%
Mkt Cap.(Cr) 184.14
Volume 6,499
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 6,499

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 52.21 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 22,733.13 -37,122.02
LAST 3M 74,205.53 -50,398.80
LAST 6M 139,333.16 -187,387.57
LAST 12M 206,053.08 -175,138.09
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
Nov 22, 2021 Dividend 12.5
Apr 27, 2021 Bonus 1:1
Jul 10, 2020 Dividend 12.5

Information

  • About Company
  • Company Info
  • Listing Info
20.27
74.21%
48.6602
24.78%
21.7%
Description
  • Par Drugs and Chemicals Limited was originally incorporated as a private limited company with the name `Par Drugs and Chemicals Private Limited` at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the company was converted into a public limited company pursuant to special resolution passed by the members in extra-ordinary general meeting of the company held on October 24, 2018 and the name of the company was changed to `Par Drugs and Chemicals Limited` on 5 November 2018. Vallabhbhai Savani and Sarita Savani were initial subscribers to the Memorandum of Association of the company. The Promoters of the company are Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani. The Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani have first shares on 19, 2006 through allotment of shares by company. The Company is engaged in the development and manufacture of Active Pharma ingredients (`APIs`) for the domestic market as well as for exports to international markets. APIs, also known as `bulk drugs` or `bulk actives` are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company produce various range of Antacid Molecules which are available in the market and are in great demand. The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals. The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.

Read More

No Data Found

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 535341
NSE Code : PAR
Book Closure Date (Month) : Jul
BSE Group :
ISIN : INE04LG01015

ICICIdirect Par Drugs & Chemicals Ltd FAQ

You can buy Par Drugs & Chemicals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Par Drugs & Chemicals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 24, 2022 03:50 PM the closing price of Par Drugs & Chemicals Ltd was ₹ 149.65.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 24, 2022 03:50 PM, the market cap of Par Drugs & Chemicals Ltd stood at ₹ 184.14.
The latest PE ratio of Par Drugs & Chemicals Ltd as of May 24, 2022 03:50 PM is 20.27
The latest PB ratio of Par Drugs & Chemicals Ltd as of May 24, 2022 03:50 PM is 0.32
The 52-week high of Par Drugs & Chemicals Ltd is ₹ 310.60 while the 52-week low is ₹ 60.10 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE